Social bias in artificial intelligence algorithms designed to improve cardiovascular risk assessment relative to the Framingham Risk Score: a protocol for a systematic review

被引:0
|
作者
Garcha, Ivneet [1 ]
Phillips, Susan Paula [2 ]
机构
[1] Queens Univ, Med, Kingston, ON, Canada
[2] Queens Univ, Dept Family Med, Kingston, ON, Canada
来源
BMJ OPEN | 2023年 / 13卷 / 05期
关键词
primary care; preventive medicine; social medicine; cardiology;
D O I
10.1136/bmjopen-2022-067638
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionCardiovascular disease (CVD) prevention relies on timely identification of and intervention for individuals at risk. Risk assessment models such as the Framingham Risk Score (FRS) have been shown to over-estimate or under-estimate risk in certain groups, such as socioeconomically disadvantaged populations. Artificial intelligence (AI) and machine learning (ML) could be used to address such equity gaps to improve risk assessment; however, critical appraisal is warranted before ML-informed clinical decision-making is implemented.Methods and analysisThis study will employ an equity-lens to identify sources of bias (ie, race/ethnicity, gender and social stratum) in ML algorithms designed to improve CVD risk assessment relative to the FRS. A comprehensive literature search will be completed using MEDLINE, Embase and IEEE to answer the research question: do AI algorithms that are designed for the estimation of CVD risk and that compare performance with the FRS address the sources of bias inherent in the FRS? No study date filters will be imposed on the search, but English language filters will be applied. Studies describing a specific algorithm or ML approach that provided a risk assessment output for coronary artery disease, heart failure, cardiac arrhythmias (ie, atrial fibrillation), stroke or a global CVD risk score, and that compared performance with the FRS are eligible for inclusion. Papers describing algorithms for the diagnosis rather than the prevention of CVD will be excluded. A structured narrative review analysis of included studies will be completed.Ethics and disseminationEthics approval was not required. Ethics exemption was formally received from the General Research Ethics Board at Queen's University. The completed systematic review will be submitted to a peer-reviewed journal and parts of the work will be presented at relevant conferences.
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Waterlow score for risk assessment in surgical patients: a systematic review
    Nayar, S. K.
    Li, D.
    Ijaiya, B.
    Lloyd, D.
    Bharathan, R.
    ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2021, 103 (05) : 312 - 317
  • [32] USING ARTIFICIAL INTELLIGENCE TO UNCOVER ASSOCIATION OF LEFT ATRIAL STRAIN WITH THE FRAMINGHAM RISK SCORE FOR ATRIAL FIBRILLATION DEVELOPMENT
    Ahmad, Ali
    Mansour, Shareef
    Zgheib, Ali
    Safatly, Lise
    El Hajj, Ali
    Baydoun, Mohamad
    Ghaziri, Hassan
    Aridi, Hussam
    Ismaeel, Hussain
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 455 - 455
  • [33] Risk Management and Patient Safety in the Artificial Intelligence Era: A Systematic Review
    Ferrara, Michela
    Bertozzi, Giuseppe
    Di Fazio, Nicola
    Aquila, Isabella
    Di Fazio, Aldo
    Maiese, Aniello
    Volonnino, Gianpietro
    Frati, Paola
    La Russa, Raffaele
    HEALTHCARE, 2024, 12 (05)
  • [34] Risk factors from Framingham risk score for anthracyclines cardiotoxicity in breast cancer: A systematic review and meta-analysis
    Jin, Hao
    Xu, Jianfeng
    Sui, Zheng
    Wang, Lili
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [35] A Cross-Sectional Evaluation of Cardiovascular Risk Assessment in Type 2 Diabetes Mellitus Patients Using the Framingham Risk Score
    Rathod, Mitali B.
    Moukthika, Shashum
    Karikunnel, Allwyn John
    Harika, Kottala
    Talla, Prathibha
    Jalakam, Madhurika
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
  • [36] Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis
    Webster, Emily M.
    Ahsan, Muhammad Danyal
    Perez, Luiza
    Levi, Sarah R.
    Thomas, Charlene
    Christos, Paul
    Hickner, Andy
    Hamilton, Jada G.
    Babagbemi, Kemi
    Cantillo, Evelyn
    Holcomb, Kevin
    Chapman-Davis, Eloise
    Sharaf, Ravi N.
    Frey, Melissa K.
    JCO CLINICAL CANCER INFORMATICS, 2023, 7 : e2300123
  • [37] Integration of cardiovascular risk assessment with COVID-19 using artificial intelligence
    Suri, Jasjit S.
    Puvvula, Anudeep
    Majhail, Misha
    Biswas, Mainak
    Jamthikar, Ankush D.
    Saba, Luca
    Faa, Gavino
    Singh, Inder M.
    Oberleitner, Ronald
    Turk, Monika
    Srivastava, Saurabh
    Chadha, Paramjit S.
    Suri, Harman S.
    Johri, Amer M.
    Nambi, Vijay
    Sanches, J. Miguel
    Khanna, Narendra N.
    Viskovic, Klaudija
    Mavrogeni, Sophie
    Laird, John R.
    Bit, Arindam
    Pareek, Gyan
    Miner, Martin
    Balestrien, Antonella
    Sfikakis, Petros P.
    Tsoulfas, George
    Protogerou, Athanasios
    Misra, Durga Prasanna
    Agarwal, Vikas
    Kitas, George D.
    Kolluri, Raghu
    Teji, Jagjit
    Porcu, Michele
    Al-Maini, Mustafa
    Agbakoba, Ann
    Sockalingam, Meyypan
    Sexena, Ajit
    Nicolaides, Andrew
    Sharma, Aditya
    Rathore, Vijay
    Viswanathan, Vijay
    Naidu, Subbaram
    Bhatt, Deepak L.
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2020, 21 (04) : 541 - 560
  • [38] Artificial intelligence-based risk assessment tools for sexual, reproductive and mental health: a systematic review
    Islam, Shifat
    Shahriyar, Rifat
    Agarwala, Abhishek
    Zaman, Marzia
    Ahamed, Shamim
    Rahman, Rifat
    Chowdhury, Moinul H.
    Sarker, Farhana
    Mamun, Khondaker A.
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2025, 25 (01)
  • [39] Chatbot Artificial Intelligence for Genetic Cancer Risk Assessment and Counseling: A Systematic Review and Meta-Analysis
    Webster, Emily M.
    Ahsan, Muhammad Danyal
    Perez, Luiza
    Levi, Sarah R.
    Thomas, Charlene
    Christos, Paul
    Hickner, Andy
    Hamilton, Jada G.
    Babagbemi, Kemi
    Cantillo, Evelyn
    Holcomb, Kevin
    Chapman-Davis, Eloise
    Sharaf, Ravi N.
    Frey, Melissa K.
    JCO CLINICAL CANCER INFORMATICS, 2023, 7
  • [40] Artificial intelligence in the risk prediction models of cardiovascular disease and development of an independent validation screening tool: a systematic review
    Cai, Yue
    Cai, Yu-Qing
    Tang, Li-Ying
    Wang, Yi-Han
    Gong, Mengchun
    Jing, Tian-Ci
    Li, Hui-Jun
    Li-Ling, Jesse
    Hu, Wei
    Yin, Zhihua
    Gong, Da-Xin
    Zhang, Guang-Wei
    BMC MEDICINE, 2024, 22 (01)